Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
2,850,581
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
1,308,185
-
Shares change
-
-1,210,640
-
Total reported value, excl. options
-
$415,023
-
Value change
-
-$388,177
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$0.311
Significant Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q3 2023
9 filings reported holding SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value as of Q3 2023.
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,308,185 shares
of 2,850,581 outstanding shares and own 45.89% of the company stock.
Largest 9 shareholders include ARMISTICE CAPITAL, LLC (974,000 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (286,100 shares), GEODE CAPITAL MANAGEMENT, LLC (20,179 shares), HRT FINANCIAL LP (18,045 shares), NATIONAL BANK OF CANADA /FI/ (6,042 shares), OSAIC HOLDINGS, INC. (3,293 shares), New England Capital Financial Advisors LLC (500 shares), Federation des caisses Desjardins du Quebec (79 shares), and MORGAN STANLEY (26 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.